Actively Recruiting

All Genders
Healthy Volunteers
NCT07234656

Patient-partnered Research in Investigating Fear of Cancer Recurrence in Kidney Cancer

Led by Brigitta Rasmussen Villumsen · Updated on 2026-04-01

105

Participants Needed

3

Research Sites

122 weeks

Total Duration

On this page

Sponsors

B

Brigitta Rasmussen Villumsen

Lead Sponsor

A

Aarhus University Hospital

Collaborating Sponsor

AI-Summary

What this Trial Is About

The goal of this observational study is to gather real-world information about Fear of Cancer Recurrence (FCR) following surgery in patients with renal cell carcinoma (RCC) and their partners/spouses by 1) establishing a panel consisting of patients with or without partners/spouses to facilitate patient-partnered research. Furthermore, 2) Through discussions among panel members and researchers identification of the most pertinent topics related to FCR, as well as the optimal timing and methods for collecting that information in the follow-up care after surgery. Finally, to conduct a feasibility and pilot study to investigate the feasibility of the recommendations developed in 1) + 2) and assess FCR in patients with RCC following surgery and their partners/spouses. In phase 1 participants (panel members) will be asked to collaborate with researchers in the development of recommendations for FCR questions, mode of administration and timing in the follow-up care after surgically treated kidney cancer. In phase 2 participants (patients and partners) in follow-up care after surgically treated kidney cancer are asked to answer questions about FCR at specific timepoints defined by panel members and researchers in phase 1.

CONDITIONS

Official Title

Patient-partnered Research in Investigating Fear of Cancer Recurrence in Kidney Cancer

Who Can Participate

All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Single patients diagnosed with Renal Cell Carcinoma (RCC) or patients with RCC in an intimate relationship with a partner/spouse
  • Partner/spouse to patients who fulfill the inclusion criteria
  • Patients have undergone surgery due to localized RCC (T1-T2-T3 tumor)
  • Time since surgery: 0-120 months (phase 1)
  • Danish speaking patients and partners/spouses able to speak, write and read Danish
  • Patients and partners/spouses able and willing to attend online project meetings or in person at Gødstrup Hospital (phase 1)
  • Able to receive digital communication from the hospital (phase 2)
  • Signed informed consent before answering Fear of Cancer Recurrence questions (phase 2)
Not Eligible

You will not qualify if you...

  • Diagnosed with cognitive impairment
  • Untreated psychiatric disorders due to non-compliance
  • Patients and partners/spouses who were panelists in phase 1 (phase 2 only)

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 3 locations

1

Aalborg University Hospital

Aalborg, Denmark, 9000

Actively Recruiting

2

Aarhus University Hospital

Aarhus, Denmark, 8200

Actively Recruiting

3

Gødstrup Hospital

Herning, Denmark, 7400

Actively Recruiting

Loading map...

Research Team

B

Brigitta R Villumsen, PhD

CONTACT

A

Anne H Nielsen, PhD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here